• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱非侵袭性乳头状尿路上皮肿瘤中MUC1和P53表达的评估、它们与肿瘤分级的关系以及在鉴别诊断中的作用。

Evaluation of MUC1 and P53 expressions in noninvasive papillary urothelial neoplasms of bladder, their relationship with tumor grade and role in the differential diagnosis.

作者信息

Kaymaz Esin, Ozer Elif, Unverdi Hatice, Hucumenoglu Sema

机构信息

Department of Pathology, Bülent Ecevit University Hospital, Zonguldak, Turkey.

Department of Pathology, Ankara Education and Research Hospital, Ankara, Turkey.

出版信息

Indian J Pathol Microbiol. 2017 Oct-Dec;60(4):510-514. doi: 10.4103/IJPM.IJPM_204_16.

DOI:10.4103/IJPM.IJPM_204_16
PMID:29323063
Abstract

PURPOSE

The aim of this study was to investigate the usability of MUC1 and p53 for differential diagnosis of noninvasive papillary urothelial neoplasias, especially for distinguishing papillary urothelial neoplasm of low malignant potential (PUNLMP) from low-grade papillary urothelial carcinoma (LGPUC) when the histologic signs are not obvious.

MATERIALS AND METHODS

Seventeen biopsy specimens of the patients with PUNLMP, 20 with LGPUC and 13 with high-grade papillary urothelial carcinoma (HGPUC) were stained for MUC1 and p53 protein by immunohistochemical methods. Histological grading was performed according to an algorithm, which allows histological parameters used in 2004 WHO/ISUP 1998.

RESULTS

We had obvious statistical difference for aberrant expression pattern of MUC1 between PUNLMP and LGPUC-HGPUC (P = 0.007). Positivity of MUC1 expression in cytoplasm of basal cells was more observed in HGPUC and LGPUC, whereas PUNLMP was more often showing apical and superficial positivity of MUC1 expression (P = 0.001 and 0.011). Nuclear p53 protein in HGPUC was obviously more frequent than that in LGPUC and PUNLMP (P < 0.001). Measures showed statistical difference among aberrant MUC1 expression, p53 overexpression, and tumor grade (P < 0.001).

CONCLUSIONS

MUC1 and p53 may be helpful immunohistochemical markers for distinguishing PUNLMP from LGPUC and HGPUC, when the histologic signs are not obvious.

摘要

目的

本研究旨在探讨MUC1和p53在非侵袭性乳头状尿路上皮肿瘤鉴别诊断中的实用性,尤其是在组织学特征不明显时,用于区分低恶性潜能乳头状尿路上皮肿瘤(PUNLMP)和低级别乳头状尿路上皮癌(LGPUC)。

材料与方法

采用免疫组化方法对17例PUNLMP患者、20例LGPUC患者和13例高级别乳头状尿路上皮癌(HGPUC)患者的活检标本进行MUC1和p53蛋白染色。根据一种算法进行组织学分级,该算法采用了2004年WHO/ISUP 1998版中使用的组织学参数。

结果

PUNLMP与LGPUC-HGPUC之间MUC1异常表达模式存在明显统计学差异(P = 0.007)。HGPUC和LGPUC中更常观察到基底细胞胞质中MUC1表达阳性,而PUNLMP更常表现为MUC1表达的顶端和浅表阳性(P = 0.001和0.011)。HGPUC中核p53蛋白明显比LGPUC和PUNLMP更常见(P < 0.001)。各项指标显示MUC1异常表达、p53过表达和肿瘤分级之间存在统计学差异(P < 0.001)。

结论

当组织学特征不明显时,MUC1和p53可能是区分PUNLMP与LGPUC和HGPUC的有用免疫组化标志物。

相似文献

1
Evaluation of MUC1 and P53 expressions in noninvasive papillary urothelial neoplasms of bladder, their relationship with tumor grade and role in the differential diagnosis.膀胱非侵袭性乳头状尿路上皮肿瘤中MUC1和P53表达的评估、它们与肿瘤分级的关系以及在鉴别诊断中的作用。
Indian J Pathol Microbiol. 2017 Oct-Dec;60(4):510-514. doi: 10.4103/IJPM.IJPM_204_16.
2
Expression of MUC1 (Ma695) in noninvasive papillary urothelial neoplasm according to the 2004 World Health Organization classification of the noninvasive urothelial neoplasm. An immunologic tool for the pathologist?根据2004年世界卫生组织非侵袭性尿路上皮肿瘤分类,MUC1(Ma695)在非侵袭性乳头状尿路上皮肿瘤中的表达。这是病理学家的一种免疫工具?
Anal Quant Cytol Histol. 2011 Oct;33(5):277-82.
3
A retrospective study on expression and clinical significance of PHH3, Ki67 and P53 in bladder exophytic papillary urothelial neoplasms.一项关于 PHH3、Ki67 和 P53 在膀胱外生性乳头状尿路上皮肿瘤中的表达及临床意义的回顾性研究。
PeerJ. 2023 Jul 11;11:e15675. doi: 10.7717/peerj.15675. eCollection 2023.
4
Cytomorphological characteristics of low-grade papillary urothelial carcinoma in voided urine samples: Distinction from benign and high-grade papillary urothelial carcinoma.尿脱落细胞中低级别乳头状尿路上皮癌的细胞形态学特征:与良性和高级别乳头状尿路上皮癌的鉴别。
Cytopathology. 2024 Nov;35(6):724-732. doi: 10.1111/cyt.13413. Epub 2024 Jul 11.
5
Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.1998年世界卫生组织/国际泌尿病理学会分类背景下低级别乳头状尿路上皮肿瘤(低度恶性潜能和低级别癌)的细胞学诊断
Diagn Cytopathol. 2003 Apr;28(4):186-90. doi: 10.1002/dc.10263.
6
Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) After Initial TUR-BT: Comparative Analyses with Noninvasive Low-Grade Papillary Urothelial Carcinoma (LGPUC).初次经尿道膀胱肿瘤电切术后低恶性潜能乳头状尿路上皮肿瘤(PUNLMP):与非侵袭性低级别乳头状尿路上皮癌(LGPUC)的比较分析
J Cancer. 2017 Aug 24;8(15):2885-2891. doi: 10.7150/jca.20003. eCollection 2017.
7
Immunohistochemical expression of p63, p53 in urinary bladder carcinoma.p63、p53在膀胱癌中的免疫组化表达。
Indian J Pathol Microbiol. 2013 Jan-Mar;56(1):10-5. doi: 10.4103/0377-4929.116141.
8
Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility.尿路上皮乳头状肿瘤的组织学分级:联合分级(双编号分级系统)对可重复性的影响。
Virchows Arch. 2011 Jun;458(6):659-64. doi: 10.1007/s00428-011-1072-3. Epub 2011 Apr 12.
9
P53 overexpression in bladder urothelial neoplasms: new aspect of World Health Organization/International Society of Urological Pathology classification.膀胱尿路上皮肿瘤中P53过表达:世界卫生组织/国际泌尿病理学会分类的新方面
Urol J. 2007 Fall;4(4):230-3.
10
Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer.非浸润性乳头状尿路上皮肿瘤(NIPUN):重新命名癌症。
Urol Oncol. 2021 May;39(5):286-290. doi: 10.1016/j.urolonc.2020.12.007. Epub 2021 Jan 1.

引用本文的文献

1
Research progress of MUC1 in genitourinary cancers.MUC1 在泌尿生殖系统癌症中的研究进展。
Cell Mol Biol Lett. 2024 Nov 3;29(1):135. doi: 10.1186/s11658-024-00654-x.
2
Altered Glycosylation in Progression and Management of Bladder Cancer.膀胱癌进展和管理中的糖基化改变。
Molecules. 2023 Apr 13;28(8):3436. doi: 10.3390/molecules28083436.
3
Enhanced plasma miR-26a-5p promotes the progression of bladder cancer via targeting PTEN.增强的血浆miR-26a-5p通过靶向PTEN促进膀胱癌进展。
Oncol Lett. 2018 Oct;16(4):4223-4228. doi: 10.3892/ol.2018.9163. Epub 2018 Jul 17.